Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
Ocuphire Pharma Inc reported Revenue of $39.85 millions, in the Dec 31 2022 report
OCUP delivered fourth quarter of 2022 operating surplus of $34.21 millions
Published Mar 31 2023
CSIMarket Team / CSIMarket.com
Ocuphire Pharma Inc have achieved net income of $33.941 millions in the financial interval ending December 31 2022 an improvement versus a net shortfall of $-6.313 millions in the similar reporting season a year ago. Ocuphire Pharma Inc also emphasized it's improving profit margins, where net margin rose to 85.17% in financial interval ending December 31 2022, and operating margin edged up to 85.85%.
the Major Pharmaceutical Preparations company realized profitability of $17.89 millions and Revenues of $39.85 millions for the financial year 2022.
Ocuphire Pharma Inc recorded earnings per share of $0.87 compare to $-3.82 in the previous financial year, while Revenue doubled by 6665.7 % from $0.59 millions a year ago.
Ocuphire Pharma Inc is expected to report next financial recent numbers on May 12, 2023.
Other OCUP's news
Ocuphire Pharma Grants Inducement Awards to Top Executives Under Nasdaq Listing Rule 5635(c)(4)
Ocuphire Pharma Accelerates Growth with Inducement Grant to New COO
Ocuphire Pharma Inc. Surges with Record-Breaking Revenue of $11.935 Million in Q3 2023
Ocuphire Pharma Inc. Records Impressive Revenue of $3.674 Million in Q2 of 2023
Ocuphire Pharma Inc reported Revenue of $39.85 millions, in the Dec 31 2022 report
Other OCUP's news
Ocuphire Pharma Grants Inducement Awards to Top Executives Under Nasdaq Listing Rule 5635(c)(4)
Ocuphire Pharma Accelerates Growth with Inducement Grant to New COO
Ocuphire Pharma Inc. Surges with Record-Breaking Revenue of $11.935 Million in Q3 2023
Ocuphire Pharma Inc. Records Impressive Revenue of $3.674 Million in Q2 of 2023
Ocuphire Pharma Inc reported Revenue of $39.85 millions, in the Dec 31 2022 report